Endymed Ltd (TLV:ENDY)

Market Cap	44.05M
Revenue (ttm)	70.42M
Net Income (ttm)	-6.76M
Shares Out	13.76M
EPS (ttm)	-0.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Average Volume	27,462
Open	320.10
Previous Close	320.10
Day's Range	320.10 - 320.10
52-Week Range	190.00 - 355.00
Beta	-0.29
RSI	64.33
Earnings Date	Mar 20, 2025

About Blueprint Medicines

Endymed Ltd provides energy based medical aesthetic treatment systems for the professional and consumer markets in North America, Europe, the Middle East, Africa, Asia, Oceania, Latin America, and internationally. The company offers ENDYMED PRO, an all-in-one treatment platform; ENDYMED PURE 2.0, a compact and flexible treatment platform; Pure Laser, a laser hair removal system; Intensif, a RF microneedle technology; FSR, a skin resurfacing tool; Focused RF, which uses 3DEEP tightening and contouring handpieces for the face, neck, and body; NEW...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 46
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ENDY

Financial Performance

In 2023, Endymed's revenue was $22.78 million, an increase of 6.77% compared to the previous year's $21.33 million. Earnings were $553,000, a decrease of -34.94%.